CLICKS GROUP LTD RC-01 risk profile
43 Elevated one input has moved against it
Measured 21 October 2026 from N1C's filed statements. Recomputed nightly.
43 (Elevated), driven by Market expectation at 59, over 5 weighted categories on the RETAILER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 59 | Elevated | Stable | Drawdown from the 52-week high — 29.4% |
| Operating pressure | 34 | Normal | Stable | Costs outgrowing revenue — -0.6 percentage points |
| Cash conversion | 42 | Elevated | Worsening | Cash conversion — 1.06x |
| Leverage and coverage | 18 | Contained | Stable | Current ratio — 1.09x |
| Competitive position | 53 | Elevated | Stable | Revenue-growth gap against peers — -9.6 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for CLICKS GROUP LTD RC-01